Companies that enroll in the 2012 CE Program receive the following courses.

Coronary Artery Calcification Testing: This will be an in-depth review testing for coronary artery calcium (CAC) and the implications of test findings in assessing all aspects of circulatory risk as well as how these findings correlate with epidemiological factors and other test results. Available Jan 1, 2012

Bilirubin and Alkaline Phosphatase: This long overdue course will examine life and morbidity underwriting implications of abnormal AP and bilirubin results in terms of what can cause them, how they are further evaluated, and how they correlate with clinical signs, symptoms, abnormal liver enzymes and other tests. In addition, we will review the burgeoning evidence of the risk implications of relatively high vs. relatively low bilirubin readings – within the “normal” range – as markers for mortality and morbidity. Available Jan 15, 2012

Respiratory Disease Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available Feb 1, 2012

Hodgkin Lymphoma: This malignancy is seen disproportionately by underwriters in relation to its prevalence because of the high cure rate. This course will cover every aspect of HL that matters in the determination of BEST CASES. Expect the definitive analysis of HL. Available March 1, 2012

Myeloproliferative Diseases: There are two main disorders of excess blood cell manufacture that have extra mortality but are sometimes readily insurable: polycythemia vera and thrombocythemia. This course will cover the latest information germane to underwriting these disorders, as well as the non-malignant causes of excess red blood cells (polycythemia, erythrocytosis) and excess platelets (thrombocytosis) which often have major risk implications we overlook. Available March 15, 2012

Metabolic Syndrome Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available April 1, 2012

Posttraumatic Stress Disorder: PTSD is becoming increasingly more prevalent. Some cases are readily insurable; others have excess mortality and potentially fulminant extra morbidity. This course will cover the latest clinic developments, thus enabling underwriters to sort these risk and pinpoint BEST and WORST cases from every relevant angle. Available May 1, 2012

Alcohol Abuse and Alcoholism: Alcohol disorders are the Achilles heel of mortality and morbidity. This course will cover every insurance-salient aspect of excess regular alcohol intake, bingeing, chronic abuse and alcohol dependency (alcoholism). When and under what circumstances can recovered alcoholics be insured? All clinical, laboratory, medical history, social and occupational history, and driving-related YELLOW and RED FLAGS will be discussed in depth. Available May 15, 2012

Blood disorder and Complete Blood Analysis (CVC) Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available June 1, 2012

Latest Developments in Tobacco Use and Insurability: This course will review key developments related to our understanding of tobacco mortality and morbidity including cigar and pipe smoking, oral tobacco use, alternative tobacco use practices such as water pipes (which are becoming more prevalent worldwide), implications of aggregate tobacco consumption (pack years), risk of relapse following all treatment alternatives and associations between tobacco use as it impacts other disorders, etc. Available July 1, 2012

Throat and Mouth Cancer: This will be a unique comprehensive assessment of leukoplakia, carcinoma in situ and invasive cancer of the lip, tongue, cheek, pharynx and larynx, as well as the phenomenon known as regional cancerization of the upper aerodigestive tract (which has profound implications for otherwise insurable oral cavity cancers and precancerous conditions). Available July 15, 2012

Rheumatological Disorders Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available Aug 1, 2012

RED FLAGS in Coronary Artery Disease: Like all of our RED FLAG courses, this one will selectively review issues related to CAD such as risk implications of conventional and new highly-sensitive troponin assays in patients seen for chest pain who are and are not diagnosed with CAD events, cardiac syndrome X, underwriting factors in chronic inflammatory diseases as they alter CAD risk, RED and YELLOW FLAGS related to approved and off-label pharmacotherapies, detecting and assessing unstable atherosclerotic plaque and much more. Available Sept 1, 2012

Emerging Infectious Disease: This will be the first comprehensive course on infectious diseases for life and morbidity underwriters in many years. It will cover insurability implications of Lyme disease, West Nile fever, antibiotic resistant strains of infectious diseases, Clostridium difficile, travel exposures to dengue, malaria and other prevalent topical diseases; Chagas disease, flu pandemics and other issues that increasingly impact mortality and morbidity in industrialized nations. Available Sept 15, 2012

Diabetes and Endocrine Disease Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available Oct 1, 2012

Congenital Heart Disease in Adults: There have been many advances in the treatment and prognosis of congenital heart disorders such as atrial and ventricular septal defects, coarctation of the aorta and patent ductus arteriosus, as well as once-uninsurable cyanotic heart diseases like Tetralogy of Fallot. These will be discussed in the context of diagnosis and treatment in adulthood; plus long-term outcomes in adults who were treated in childhood. Available Nov 1, 2012

RED FLAGS in Geriatric Underwriting: This course will dissect and analyze RED FLAGS with profound insurability implications including blood, urine and other laboratory findings as well other common test results with distinctive implications at older ages, the impact of social isolation, living alone, care-giving, sleeping problems and other factors prevalent in the elderly but often not used underwriting, subtle signs and symptoms reflective of undiagnosed diseases, etc. This course alone will pay back the entire cost of enrollment fifty-fold for companies writing business at ages 65 and over. Available Nov 15, 2012

Cardiovascular Signs and Symptoms Case Clinic: Case clinics will consist of 15 cases presented for analysis by the underwriter and followed by a complete dissection of each risk based on expert assessment. Available Dec 1, 2012